Early research (Phase 1)Study completedNCT02801435What this trial is testingIcotinib Hydrochloride Cream in Patients With Mild to Moderate PsoriasisWho this might be right forPsoriasis Betta Pharmaceuticals Co., Ltd. 41
Not applicableStudy completedNCT03059641What this trial is testingTherapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in ChinaWho this might be right forLung NeoplasmsLung Cancer, Nonsmall CellAdenocarcinoma of Lung+1 more Geneplus-Beijing Co. Ltd. 300
Testing effectiveness (Phase 2)UnknownNCT05767866What this trial is testingAssessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFRWho this might be right forTreatmentTreatment Side Effects Suzhou Puhe Pharmaceutical Technology Co., LTD 160
Testing effectiveness (Phase 2)Looking for participantsNCT06760819What this trial is testingLearn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Who this might be right forAdvanced Solid TumorsHER2 Mutation Bayer 111
Very early researchNot Yet RecruitingNCT07498595What this trial is testingTILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLCWho this might be right forEGFR-TKI-resistant Non-Small Cell Lung Cancer Tianjin Medical University General Hospital 50
Early research (Phase 1)Study completedNCT01121575What this trial is testingCombined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Pfizer 70
Large-scale testing (Phase 3)Study completedNCT00049543What this trial is testingGefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by SurgeryWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more National Cancer Institute (NCI) 503
Not applicableUnknownNCT05136014What this trial is testingEvaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid ModelWho this might be right forLung CancerLung AdenocarcinomaEGFR Activating Mutation+2 more Central Hospital, Nancy, France 200
Early research (Phase 1)Not Yet RecruitingNCT07842887What this trial is testingPhase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI ResistanceWho this might be right forEGFR-TKI-resistant Non-Small Cell Lung Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 24
Early research (Phase 1)Study completedNCT00400374What this trial is testingSecondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2Who this might be right forHead and Neck Cancer Emory University 10
Early research (Phase 1)Active Not RecruitingNCT02143466What this trial is testingAZD9291 in Combination With Ascending Doses of Novel TherapeuticsWho this might be right forAdvanced Non Small Cell Lung Cancer AstraZeneca 344
Testing effectiveness (Phase 2)Study completedNCT02879994What this trial is testingPembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung CancerWho this might be right forStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer Jonsson Comprehensive Cancer Center 11
Not applicableActive Not RecruitingNCT05370469What this trial is testingReal-Time Monitoring of Symptoms in Lung Cancer Patients Receiving Oral Targeted TherapiesWho this might be right forLung CancerEGFR Gene MutationEGFR+6 more University of Virginia 30
Large-scale testing (Phase 3)Study completedNCT01136005What this trial is testingBepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI)Who this might be right forCancerSkin Rash Impaqtt Foundation 160
Large-scale testing (Phase 3)UnknownNCT02824458What this trial is testingGefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR MutationsWho this might be right forEGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors Sun Yat-sen University 246
Testing effectiveness (Phase 2)Study completedNCT01620190What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung CancerWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer University of Washington 26
Not applicableEnrolling By InvitationNCT07122882What this trial is testingIntegrated Genomics in Oncogene-driven NSCLC With Acquired ResistanceWho this might be right forOncogene-addicted Non Small Cell Lung CancerEGFR MutationALK Fusion-positive Solid or CNS Tumors+10 more Chang Gung Memorial Hospital 40
Early research (Phase 1)Ended earlyNCT02467569What this trial is testingStudy Evaluating Hemay020 In Subjects With Advanced Solid CancerWho this might be right forNeoplasms，Non-Small Cell Lung Cancer Tianjin Hemay Pharmaceutical Co., Ltd 10
Large-scale testing (Phase 3)UnknownNCT01407822What this trial is testingErlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Guangdong Association of Clinical Trials 72
Testing effectiveness (Phase 2)Ended earlyNCT02500927What this trial is testingASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR MutationsWho this might be right forEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating Mutations Astellas Pharma Inc 31